Putney Captures Enrofloxacin Flavored Tablet Market in Deals with National Distributors
Veterinarians now have unrestricted access to Putney’s generic to Baytril® Taste Tabs®
Putney, Inc., a rapidly growing pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has launched Enrofloxacin Flavored Tablets with the three largest national veterinary distributors—Henry Schein Animal Health, MWI Veterinary Supply and Patterson Veterinary. In combination with existing and new independent distributor partnerships and Putney’s direct sales, these agreements provide unrestricted distribution of Putney’s Enrofloxacin Flavored Tablets to veterinarians nationwide. Since it has achieved full access to the veterinary marketplace, the company estimates that it has already gained in excess of 70% of the oral enrofloxacin flavored tablet market for dogs and cats, and it anticipates further market penetration going forward.
“These distributor launches have driven immediate, significant sales growth, proving that when veterinarians have easy access to our FDA approved generics, they will adopt them quickly. We are pleased that our expanded partnerships with distribution are driving market share for Putney, increasing sales for distribution reps, and helping veterinarians grow their business. Putney, its distributor partners and its veterinary customers are working together to bring the benefits of generics to pet owners and their pets,” says Jean Hoffman. Since it began distributing its Enrofloxacin Flavored Tablets through national distributors, Hoffman estimates that market share has already doubled compared to year end 2013, half a year after Putney launched its first to market generic of Baytril® Taste Tabs®. Propelled by growth across all our products, Putney’s monthly revenues have jumped 50%.
For a complete list of Putney’s products and the distributors carrying them, visit www.putneyvet.com/products.About Putney
Putney is a pharmaceutical company committed to providing high quality, fairly priced generic medicines for pets. Putney’s reliable supply of affordable drug options empowers veterinarians, allowing them to provide the best possible medicine at the best possible price, and supports pet owners, helping them afford to comply with veterinary recommendations. Putney’s ongoing investment in research and development is focused on creating the next generation of generic veterinary products based on inputs from companion animal veterinarians and its industry partners. Learn more at www.putneyvet.com.
( Press Release Image: http://photos.webwire.com/prmedia/3/191405/191405-1.jpg )
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.